STUART S. KASSAN, M.D.; TERRY L. THOMAS, M.S.; HARALAMPOS M. MOUTSOPOULOS, M.D.; ROBERT HOOVER, M.D.; ROBERT P. KIMBERLY, M.D.; DANIEL R. BUDMAN, M.D.; JOSE COSTA, M.D.; JOHN L. DECKER, M.D.; THOMAS M. CHUSED, M.D.
The risk of cancer was ascertained in 136 women with sicca syndrome followed at the National Institutes of Health (NIH). Seven patients developed non-Hodgkin's lymphoma from 6 months to 13 years after their first admission to NIH. This was 43.8 times (P < 0.01) the incidence expected from the rates of cancer prevailing among women of the same age range in the general population during this time. In addition, three cases of Waldenström's macroglobulinemia occurred in this study group. Eight patients developed cancers other than lymphoma, similar to the number expected based on the rates prevailing in the general population. Patients with a history of parotid enlargement, splenomegaly, and lymphadenopathy had an increased risk of lymphoma. These clinical conditions did not appear to be early manifestations of undiagnosed lymphoma but rather seemed to identify a subgroup of patients with sicca syndrome with marked lymphoid reactivity, who had a particularly high risk of subsequently developing lymphoma.
STUART S. KASSAN, TERRY L. THOMAS, HARALAMPOS M. MOUTSOPOULOS, ROBERT HOOVER, ROBERT P. KIMBERLY, DANIEL R. BUDMAN, et al. Increased Risk of Lymphoma in Sicca Syndrome. Ann Intern Med. 1978;89:888–892. doi: 10.7326/0003-4819-89-6-888
Download citation file:
Published: Ann Intern Med. 1978;89(6):888-892.
Hematology/Oncology, Leukemia/Lymphoma, Rheumatology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use